AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q2 2020. The put-call ratio across all filers is 3.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,188 | +60.3% | 59,642 | +60.3% | 0.01% | +33.3% |
| Q1 2024 | $741 | -61.0% | 37,214 | -60.4% | 0.01% | -66.7% |
| Q3 2023 | $1,900 | +43.0% | 93,976 | +80.8% | 0.02% | +63.6% |
| Q2 2023 | $1,329 | +498.6% | 51,976 | +595.1% | 0.01% | +450.0% |
| Q1 2023 | $222 | -100.0% | 7,477 | -65.1% | 0.00% | -77.8% |
| Q1 2022 | $718,000 | +124.4% | 21,428 | +132.5% | 0.01% | +200.0% |
| Q4 2021 | $320,000 | -64.2% | 9,216 | -67.8% | 0.00% | -75.0% |
| Q3 2021 | $893,000 | -68.2% | 28,634 | -62.9% | 0.01% | -61.3% |
| Q2 2021 | $2,806,000 | +193.2% | 77,160 | +252.6% | 0.03% | +121.4% |
| Q1 2021 | $957,000 | -68.6% | 21,884 | -67.1% | 0.01% | -53.3% |
| Q4 2020 | $3,050,000 | -33.1% | 66,480 | -51.6% | 0.03% | -67.0% |
| Q3 2020 | $4,560,000 | +62.3% | 137,237 | +43.6% | 0.09% | +24.7% |
| Q2 2020 | $2,809,000 | +430.0% | 95,578 | +385.2% | 0.07% | +151.7% |
| Q1 2020 | $530,000 | – | 19,699 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 1,690,501 | $72,151,000 | 5.50% |
| Palmer Knight Co | 79,752 | $3,404,000 | 3.15% |
| Sandhill Capital Partners LLC | 374,258 | $15,973,000 | 2.23% |
| Malaga Cove Capital, LLC | 52,276 | $2,231,000 | 1.36% |
| MOODY ALDRICH PARTNERS LLC | 91,206 | $3,893,000 | 1.09% |
| Champlain Investment Partners, LLC | 2,401,987 | $102,517,000 | 0.89% |
| Channing Capital Management, LLC | 424,782 | $18,130,000 | 0.84% |
| Krensavage Asset Management, LLC | 62,057 | $2,649,000 | 0.72% |
| BROADVIEW ADVISORS LLC | 47,650 | $2,034,000 | 0.55% |
| PURA VIDA INVESTMENTS, LLC | 87,500 | $3,735,000 | 0.53% |